Clinical Updates
Launch of Generic Exalgo® Extended Release Tablets
The generic equivalent of Exalgo® extended release tablets (hydromorphone hydrochloride) has just been released, following…
FDA Recommends Decreased Dosage Of Lunesta
The U.S. Food and Drug Administration (FDA) has released a Safety Announcement which states: “The…
Launch of Generic Lovaza® Capsules
The generic equivalent of Lovaza® capsules (omega-3-acid ethyl esters) has just been released, following FDA…
Lunesta Generic Release
The generic equivalent of Lunesta tablets (eszopiclone) has been released, following FDA approval. Lunesta is…
New Medication – Zohydro
Zohydro, a new opioid narcotic painkiller, has recently been released in the 10mg, 15mg, and…
Generic Avinza Capsules
The generic equivalent of Avinza capsules (Morphine Sulphate capsules, extended release) has just been released,…
Micardis Generic Release
The generic equivalent of Micardis tablets (telmisartan) has just been released, following FDA approval. Micardis…
REMOVAL OF CODEINE FROM THE MARKET
In its January 10, 2014 notice in the Federal Register, the FDA ordered drug companies…
Generic Detrol LA Capsules®
On Thursday, January 2, Teva Pharmaceuticals launched the generic equivalent of Detrol LA® extended-release capsules…
Cymbalta® Delayed-Release Capsule Launch
Effective December 11, 2013, the generic equivalent of Cymbalta® delayed-release capsules (duloxetine HCI) was released,…
